Price T Rowe Associates Inc Mimedx Group, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 46,446 shares of MDXG stock, worth $377,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,446
Previous 39,257
18.31%
Holding current value
$377,141
Previous $233,000
91.85%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MDXG
# of Institutions
232Shares Held
101MCall Options Held
34.6KPut Options Held
36.5K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$229 Million62.7% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$75.6 Million0.0% of portfolio
-
Trigran Investments, Inc.7.62MShares$61.9 Million9.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.71MShares$54.4 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$37.9 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $923M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...